HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

g209-2M melanoma peptide

Subscribe to New Research on g209-2M melanoma peptide

Also Known As:

G9-209-2M protein, human; g209-2M protein, human

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Houghton, Alan: 1 article (01/2006)
2.	Niedzwiecki, Donna: 1 article (01/2006)
3.	Haluska, Frank G: 1 article (01/2006)
4.	Johnson, Jeffrey: 1 article (01/2006)
5.	Ernstoff, Marc S: 1 article (01/2006)
6.	Carson, William E: 1 article (01/2006)
7.	Hodi, F Stephen: 1 article (01/2006)
8.	Chapman, Paul B: 1 article (01/2006)
9.	Cancer and Leukemia Group B: 1 article (01/2006)
10.	Leong, Stanley P: 1 article (01/2006)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2006 - "Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901."
2.	Melanoma (Melanoma, Malignant) 01/01/2006 - "Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901."
3.	Leukemia 01/01/2006 - "Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901."

Related Drugs and Biologics

1.	Interleukin-2 (IL2)